Skip to content

The clinical effect of 15-day oral Tranexamic acid in total knee arthroplasty with no tourniquet

The clinical effect of 15-day oral Tranexamic acid in total knee arthroplasty with no tourniquet

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17012264
Enrollment
Unknown
Registered
2017-08-06
Start date
2017-08-06
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

A:Pre-operation 2hrs, post operation 3hrs, 9hrs 2g po TXA
B:Pre-operation 2hrs, post operation 3hrs, 9hrs 2g po TXA with a 24 interval to discharge, 1g txa to POD 14

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Primary unilateral total knee artropasty; (2) Normal platelet and coagulation function preoperatively; (3) Normal intravenous ultrasound in the lower extremities preoperatively; (4) To be able to and willing to provide signed informed consent.

Exclusion criteria

Exclusion criteria: (1) Systemic infections such as pulmonary infection or urinary tract infection are not controlled preoperatively; (2) Abnormal immune function or combined immune-related disease preoperatively; (3) Abnormal inflammatory index preoperatively (C-reactive protein >20 mg/L); (4) Abnormal fibrinolysis index preoperatively (FDP > 5mg/L); (5) Discontinuation of oral anticoagulants or aspirin less than 1 week; (6) Allergy to tranexamic acid (TXA) or dexamethasone or have contraindications; (7) Patients at high risk of thrombosis; (8) History of deep vein thrombosis (VTE, calf muscle vein thrombosis or superficial vein thrombosis, pulmonary embolism); (9) serious liver and kidney dysfunction.

Design outcomes

Primary

MeasureTime frame
haemoglobin level;womac;kss;Transfusion volue;ESR, CRP, IL-6;ROM; deep vein thrombosis ;cost;sweeling;nausea and vomiting;ecchymosis;length of hospital stay;pain scale;reoperation;survival of the prosthesis;

Countries

China

Contacts

Public ContactZhou Zongke

West China Hospital, Sichuan University

zongke@126.com+86 18980601028

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 1, 2026